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Abstract
Inhibition of the atrial ultra-rapid delayed rectifier potassium current (IKur) represents a promising therapeutic strategy in the
therapy of atrial fibrillation. However, experimental and clinical data on the antiarrhythmic efficacy remain controversial. We
tested the hypothesis that antiarrhythmic effects of IKur inhibitors are dependent on kinetic properties of channel blockade.
A mathematical description of IKur blockade was introduced into Courtemanche-Ramirez-Nattel models of normal and
remodeled atrial electrophysiology. Effects of five model compounds with different kinetic properties were analyzed.
Although a reduction of dominant frequencies could be observed in two dimensional tissue simulations for all compounds,
a reduction of spiral wave activity could be only be detected in two cases. We found that an increase of the percent area of
refractory tissue due to a prolongation of the wavelength seems to be particularly important. By automatic tracking of spiral
tip movement we find that increased refractoriness resulted in rotor extinction caused by an increased spiral-tip
meandering. We show that antiarrhythmic effects of IKur inhibitors are dependent on kinetic properties of blockade. We find
that an increase of the percent area of refractory tissue is the underlying mechanism for an increased spiral-tip meandering,
resulting in the extinction of re-entrant circuits.
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Introduction
Atrial fibrillation (AF) is the most common sustained arrhythmia
in the elderly and is associated with serious health consequences.
In search for novel therapeutic strategies, much effort has been
made to identify pharmacological targets for an atrial specific anti-
arrhythmic drug therapy [1,2]. Therapeutic strategies that either
restore the conduction velocity (CV) or increase action potential
duration (APD) are thought to be effective in terminating
fibrillatory activity and maintaining sinus rhythm [3]. Because
the ultra-rapidly activating delayed rectifier current (Ikur) is
virtually absent in human ventricles but highly expressed in the
atria, it has been proposed to be a promising target for atrial-
selective antiarrhythmic therapy [4]. Indeed, several studies show
that pharmacological IKur inhibition affects atrial action potential
(AP) configuration and prolongs APD in trabeculae from AF atria
[5,6]. Therefore, much effort has been devoted to identifying
selective pharmacological inhibitors of human IKur current.
Although selective IKur inhibition theoretically represents an
effective mechanism in AF therapy, clinical data are somewhat
conflicting. Olson and co-workers reported a loss-of-function
mutation within the Kv1.5 potassium channel, the molecular basis
of human IKur, as the cause of a form of familial AF [7].
Furthermore, pharmacological inhibition of IKur has been
associated with both anti- and pro-arrhythmic effects on human
atrial cells [6,8–13]. These obvious inconsistencies might be
explained by individual kinetic properties of the different IKur
inhibitors, including time- and voltage-dependence of block as well
as simultaneous inhibitory effects on other cardiac ion channels
[14].
Using a mathematical model of chronic atrial fibrillation (cAF)
we first analyzed the influence of time- and voltage-dependence of
IKur inhibition on basic electrophysiological tissue properties. A
simplified two-dimensional in silico model of cAF was then applied
to test the hypothesis that functional reentry and termination of AF
is influenced by the kinetic properties of inhibitory compounds.
Our results show that antiarrhythmic properties of IKur inhibitors
are strongly dependent on the ability to prolong the wavelength
thereby reducing the percent area of non-refractory space.
Models
Mathematical model description
The Courtemanche, Ramirez, Nattel (CRN) model [15] is a
mathematical model of the AP based on ionic current data
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obtained from human atrial cells. It describes the electrical
behavior of the cell with a set of nonlinear-coupled ordinary
differential equations that reconstruct ion concentrations, ionic
currents, bindings to intracellular structures, and the transmem-
brane voltage.
The occurrence and perpetuation of AF can be favored by
changes in the electrical, structural and contractile function of the
atria, a process termed ‘‘atrial remodeling’’. Electrical remodeling
is commonly promoted by AF itself and is thought to be due to the
high rate of atrial activation [16]. Alterations caused by electrical
remodeling mainly relate to altered ion current densities and can
be integrated into the CRN model by adapting the maximal
conductance of the affected channels to fit the experimentally
observed changes [17]. In short, the implemented changes are an
increase of IK1 by 110%, and a decrease of ICa,L and Ito by each
65%. Additionally, the tissue conductivity was reduced by 30% in
order to reflect gap junction remodeling.
Implementation of time and voltage dependence of IKur
blockade





where gKur is the maximum conductance, ua is the activation
gating variable, ui is the inactivation gating variable, Vm is the
transmembrane voltage, and EK is the Nernst voltage. To simulate
the human atrial AP with voltage- and time-dependent block of
IKur, the equation was modified according to Tsujimae et al. [14]













where y‘,Kur is the steady state value of yKur and tyKur is the time
constant. y‘,Kur describes the voltage dependence of the blockade
and is expressed by a Boltzmann function with a half-maximum





By this way, a form of blockade was described where IKur is not
inhibited at hyperpolarized voltages whereas at large depolarized
voltages 90% of the channels can be blocked. The time





where tonset is the time constant for the activation of channel
inhibition and trecovery the time constant for recovery from
inhibition. Since different agents seemed to block the channel
preferentially in the open state, tonset describes the time constant at
large depolarized voltages. In contrast, channels recover from
inhibition after repolarization. Therefore, trecovery describes the
time constant at large hyperpolarized voltages. A variation of both
parameters results in a different time-dependence of the blockade.
Tissue simulations
In order to simulate excitation propagation, the monodomain
model was used. It was implemented in the simulation framework
acCELLErate [18] in which the Rush–Larsen scheme for gating
variables and a forward Euler scheme for the remaining ODEs
was used. To discretize the spatial equations, the finite difference
method was applied with a time increment of 10 ms and a space
step of 0.1 mm. For the one-dimensional investigations, e.g.
effective refractory period (ERP) and CV restitution, we used a
tissue strand of 20 mm60.1 mm60.1 mm. For the analysis of the
CV of the waveback, a tissue strand of 60 mm60.1 mm60.1 mm
was used. The two-dimensional tissue patch to calculate fibrillatory
waves was composed of 100 mm6100 mm60.1 mm. We adapted
the isotropic conductivity for the tissue simulations to obtain a CV
of <750 mm/s at a basic cycle length (BCL) of 1 s in the normal
case.
APD, ERP, CV and WL restitution were calculated as
described in [19]. To initiate fibrillatory waves in the 2D tissue
patch, a specific stimulation protocol was applied. First, the left
side of the patch was stimulated for 4 beats with a BCL of 0.3 s to
obtain a plane wave. Subsequently, a cross-field stimulus in the
lower half of the patch was applied during a time where half of the
patch remained still in the refractory period of the last plane wave
activation. This created a new excitation front into the left half of
the patch but not into the right one. This broken excitation front
quickly developed into a spiral wave. To split the spiral wave in
many rotors, several impulses were set at different places each in
the front of the excitation. With this stimulation protocol 5 stable
rotors could be initiated in the case of cAF. The trajectories of the
spiral cores were tracked with an algorithm presented in [19].
Percent area of refractory tissue
The percentage of refractory tissue was determined by
retrieving the value of the h-variable of the sodium current:
INa~gNam
3h(Vm{ENa), ð6Þ
of each cell. Depending on the state of the inactivation gate, the h-
value varies between values of 0 and 1. For our analysis, cells were
defined as refractory when the h-value was below a cutoff of 0.5.
This threshold has shown a good correlation with excitability in
human atrial tissue (unpublished data).
Frequency analysis
The extracellular electrical potential We(P,t) at a position P in an









where Im is the electrical source current and r the distance from
the position P to the current source. This approximation assumes
that the electrical conductivity of both the extracellular space, and
the medium external to the tissue equals to s.
The pseudo-ECG was calculated as the difference between the
signals at positions P1 and P2, both situated in the center of the 2D
patch 10 mm apart from each other and with a distance of 5 mm
from the tissue,
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pseudo-ECG tð Þ~We P1,tð Þ{We P2,tð Þ: ð8Þ
By calculating the power spectral density of the pseudo-ECG using
the Fast Fourier Transform, the dominant frequency (DF) can be
determined as the peak in the signal.
Results
Electrophysiological characteristics of atrial tissue under
AF-induced remodeling
The aim of this study was to dissect antiarrhythmic mechanisms
of different kinetic properties of IKur inhibition on functional
reentry and AF termination using an in silico model of atrial tissue.
To create a model of chronic AF, we first integrated the
electrophysiological remodeling processes into the cellular model
[17]. Compared to the physiological situation, cAF cells showed
distinct electrophysiological properties, similar to those observed in
human experimental data [20]. In line with previous data [14], we
show that the AP shape is severely altered in cAF cells, exhibiting a
triangulation and profound shortening. For example, the APD at
30, 70 and 90% of repolarization (APD30, APD70 and APD90)
were reduced from 140 ms, 230 ms, and 300 ms in normal atrial
cells to 40 ms, 100 ms, and 129 ms in cAF cells, respectively
(Figure 1A). To further assess the frequency dependence
(restitution) of the ERP, CV and wavelength (WL), we extended
our analysis to one-dimensional tissue strips at increasing pacing
rates. In line with the results obtained in the single cell simulations
the ERP exhibited a severe reduction in cAF atrium (Figure 1B).
At a diastolic interval of 500 ms, the ERP was reduced from
320 ms to 137 ms. In agreement with human data, electrophys-
iological remodeling also resulted in a reduction of the CV [21]. In
our simulations, the CV was reduced from 761 mm/s to 598 mm/
s at a diastolic interval of 500 ms (Figure 1C). Since the WL is the
product of ERP and CV, the effects of atrial remodeling on the
WL were even more pronounced. At the same diastolic interval,
the WL was reduced from 243 mm to 82 mm in the cAF tissue,
resulting in a higher susceptibility for the occurrence and
maintenance of multiple spiral waves (Figure 1D).
Pharmacological properties of IKur blockade
In vivo and in silico experiments have demonstrated the ability of
IKur inhibitors to prolong APD in cAF cells [6]. However, the AP
modification strongly depends on the pharmacological character-
istics of channel blockade [14]. To analyze the association between
the time- and voltage dependence of IKur block and its
antiarrhythmic efficacy, we established a set of five different
model compounds of IKur block (Table 1). Whereas compound #1
represents a fictitious IKur blocker with putative ideal antiarrhyth-
mic properties on the basis of the publication by Tsujimae et al.
[14], compound #2 and #3 relate to kinetics of diphenyl
phosphine oxides (DPO), a recently described group of potent IKur
inhibitors [14,22]. Compound #4 was included to simulate slow
onset and fast recovery kinetics, as an opposite situation of #1.
Compound #5 represents a tonic blockade, mimicking a loss-of-
function mutation. Figure 2A displays the pharmacological effects
of the different model compounds on a simulated current trace
elicited by a rectangular voltage step applied with a frequency of
1 Hz (see inset). When applied to normal atrial cells, IKur
inhibition had marked effects on the AP trajectory, especially
within the plateau phase (Figure 2B). However, none of the model
compounds caused a relevant prolongation of the terminal phase
of the atrial AP. These results are in line with experimental data
showing that the effect of IKur inhibition on APD is strongly
dependent on the degree of electrical remodeling [6]. As expected,
atrial APD was prolonged for most of the model compounds when
tested in cAF tissue (Figure 2C). Whereas compound #1, #2, and
#3 resulted in a relevant prolongation of the terminal repolari-
zation phase (APD90), compounds #1 and #3 additionally
elevated the potential of the plateau phase (Table 2). This
particular effect was reflected by a strong modification of APD30
by compound #1 and #3, resulting in a prolongation from 40 ms
to 110 ms and 103 ms, respectively. These findings agree with
previously published data on simulated IKur inhibition in
remodeled atrial tissue [23]. Furthermore, as proposed by
Tsujimae et al. [14], the overall AP prolongation showed a strong
dependence on pharmacological properties, with the most
pronounced prolongation resulting from compounds with slow
time constants of recovery (Table 1). By analyzing time course of
unblocked IKur during a simulated AP at a heart rate of 1 Hz, we
found that compound #2 and #4 accomplished a complete
dissociation from the channel during the diastolic interval, whereas
compound #1 and #3 accumulated (Figure 2D). This effect might
explain the profound effect of the slowly dissociating compounds
on atrial AP in both normal, and cAF cells (Figure 2B, C).
Electrophysiological properties of remodeled tissue
under pharmacological inhibition
We next analyzed the pharmacological effects of the IKur
blockade in dependence of the diastolic interval (restitution curve).
With decreasing diastolic intervals, the APD exhibited a decrease
for cAF control tissue, as well as all of the inhibitory model
compounds (Figure 3A). Again, the most pronounced effect could
be observed for compound #1 and #3 exhibiting slow unbinding
characteristics. Below a specific diastolic interval, the APD of even
and odd beats started alternating between two distinct values. This
well-recognized phenomenon, termed electrical alternans, has
been associated with the steepness of the restitution curve and
might predispose to wavebreak [24,25]. Indeed, in our experi-
ments electrical alternans occurred earlier in cases of steep
restitution curves (compounds #1, #2 and #3). However,
wavebreak could not be observed in any of our 2D simulations
(Fig. 4A). Analyzing the minimum diastolic interval, we find that
compared to the control condition (42 ms) all test compounds
resulted in a decrease of the minimum diastolic interval to values
of 23 ms (#1), 24 ms (#2), 22 ms (#3), 26 ms (#4), and 25 ms
(#5). These results suggest that the ERP is quite close to the APD.
As expected from these results, the ERP restitution curve of the
control condition and all test compounds strongly resembled the
APD restitution (Fig. 3B). Next, effects of IKur inhibition on the
restitution of the CV were analyzed. As expected from a pure
inhibitor of repolarizing potassium current, no marked effect on
the CV restitution could be observed (Figure 3C). Furthermore,
using a long (6 cm) 1D tissue strip, effects of the different
compounds on the waveback speed were analyzed. We find that
the CV of the waveback did not differ from the CV of the
wavefront (data not shown). The stability and occurrence of
reentrant circuits was strongly dependent on the WL. Since the
CV was identical for all model compounds in our simulations, the
restitution curve of the WL strongly resembled the APD and ERP
restitution, exhibiting the most pronounced WL prolongation for
compound #1 and #3 (Fig. 3D).
Tissue simulation and analysis of spiral waves
The electrophysiological effects of every IKur inhibitor were next
analyzed in a simplified two-dimensional simulation of chronic
remodeled atrium. We first analyzed whether the observed WL
prolongation is reflected by an increase in the percent area of
Rotor Termination by IKur Inhibition
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refractory tissue. For this purpose, a single rotor was induced using
a simple cross-field stimulation protocol. Inhibition was started
after 1 second and the rotor was followed over a time period of
5 seconds. Figure 4A displays the activation pattern at the end of
the simulation for the control condition and all test compounds.
The percent area of refractory space was determined by retrieving
the value of the inactivation variable (h) of the sodium channel
from all cells. Cells exhibiting a h-value greater or equal to 0.5
were defined as excitable. The mean percent area of refractory
tissue during the last 4 seconds of inhibition is depicted in Fig. 4B.
Under control conditions, the mean percent area of refractory
space revealed 17.1% (Fig. 4B). Comparable values could be
obtained for compound #2 (16.8%), #4 (16.6%), and #5 (16.2%)
(Fig. 4B). Of note, the slightly lower values of these test compounds
compared to the control conditions might be due to decreased
spatial stability of the rotors. Interestingly, refractoriness was
increased to 22.2 and 19.1% for compound #1 and #3,
respectively. These values correspond well with the pronounced
effect of these compounds on the wavelength (Fig. 3D).
Next, effects of the compounds on multiple wavelets were
studied. In our remodeled atrial model, a number of five rotors
could be easily induced within an area of 100 cm2 using a cross-
field stimulation protocol with additional stimuli under control
conditions [17]. Of note, no stable rotor could be induced in our
two-dimensional model of atrial tissue lacking electrophysiological
remodeling (data not shown). This might be mainly attributed to
the relation between the wavelength and the size of the 2D model
and is in line with previous studies showing that stable rotors can
only be induced in more realistic 3D models [26–28]. The
electrical activity of the tissue sample was followed over a period of
30 seconds. Figure 5 depicts representative activation patterns
under control conditions (cAF without compound). To further
analyze the electrical activity we calculated a pseudo-ECG
(Figure 5B). For this purpose, two virtual electrodes were placed
5 mm distant from the tissue, from which potential changes were
measured. Using Fast Fourier Transformation, the dominant
frequencies in the power spectral density could be obtained
(Figure 5C). Under control conditions, a dominant frequency was
detected at 6.59 and 8.73 Hz, corresponding to dominant
frequencies obtained from ECGs of AF patients [29]. Next, we
used an automated algorithm (see methods section) to automat-
ically track the number of spiral waves. We found that under
control conditions the initially established number of 5 rotors
persisted over the complete time interval with only minor changes
until the end of the simulation (Figure 5D).
Rotor stability under pharmacological IKur inhibition
To analyze antiarrhythmic properties, rotors were induced in a
tissue probe of cAF tissue as described above. As soon as five stable
rotors had established (after 4 s), the inhibitory model compounds
Figure 1. Electrophysiological properties of cAF tissue. (A) Simulated AP recordings of isolated cells from normal (solid line) and remodeled
atrial tissue (dashed line). (B) Restitution of ERP under physiological conditions (solid lines) and cAF (dashed lines). (C, D) CV and WL restitution for
physiological conditions (solid lines) and cAF (dashed lines).
doi:10.1371/journal.pone.0083179.g001
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were added one at a time. The effects on the number of spiral
waves were again followed over a time period of 30 seconds.
Under control conditions, the number of 5 spiral waves persisted
over the complete time period (Figure 6A). Similar results were
obtained for compounds #2, #4 and #5 (Figure 6A). In contrast,
the number of spiral waves was effectively reduced to 3 and 1 rotor
after 30 seconds, when adding the inhibitory compounds #1 and
#3, respectively (Figure 6A).
Wavelength prolongation has been shown to reduce rotor
frequency by enlarging the reentrant circle [30]. In agreement
with to our observed effects of the inhibitory compounds on APD
and ERP (Figure 2C, 3A, 3B, 3D), the spectral analysis of
dominant frequencies revealed a reduction of the dominant
frequencies for all conditions (Figure 6B). Although these effects
were observed even for compounds with no effect on the number
Figure 2. Pharmacological properties of simulated IKur inhibition. (A) Effect of inhibition on IKur elicited by a simulated voltage step (500 ms)
to +30 mV (see inset). (B) Effect of the different inhibitory model compounds on AP trajectories in cells from normal atrial tissue. (C) Depending on
the kinetic properties, IKur inhibition resulted in an elevation of the plateau potential (#1, #2, and #3) as well as AP prolongation (#1, #2, #3, and
#5) in cells from cAF tissue. (D) Effects of onset and recovery time constants on the non-blocked fraction of IKur blockade established at a pacing rate
of 1 Hz. The underlying AP derived from a cAF cell is depicted in a dashed line.
doi:10.1371/journal.pone.0083179.g002
Table 1. Kinetic properties of IKur inhibitors.
Compound tonset (ms) trecovery (ms) Properties
#1 5 1000 fast onset, slow recovery
#2 16 238 fast onset, fast recovery
#3 100 16000 slow onset, slow recovery
#4 200 250 slow onset, fast recovery
#5 n/a n/a tonic block
doi:10.1371/journal.pone.0083179.t001
Table 2. Differential effect of IKur inhibitors on action
potential configuration in remodeled atrial tissue.
Compound APD30 (ms) APD70 (ms) APD90 (ms)
Control 40 100 129
#1 110 156 182
#2 91 146 174
#3 103 150 176
#4 43 105 134
#5 66 122 150
doi:10.1371/journal.pone.0083179.t002
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Figure 3. Electrophysiological properties of remodeled atrial tissue under IKur inhibition. Restitution curves of the APD (A), ERP (B), CV (C),
and WL (D) under different types of IKur inhibition. Whereas APD, ERP, and WL restitution exhibits a strong dependence on kinetic properties of IKur
inhibitors, the CV is not affected.
doi:10.1371/journal.pone.0083179.g003
Figure 4. Percent area of refractory tissue. (A) Spiral wave activity of a single rotor under control cAF conditions and after inhibition with all five
test compounds displayed at the end of the 5th second. The transmembrane voltage is color-coded with blue representing 280 mV and yellow
representing 0 mV. (B) Summarized data of the mean percentage of refractory tissue quantified over the last 4 seconds of inhibition (control: 17.2%,
#1: 22.2%, #2: 16.8%, #3: 19.1%, #4: 16.6%, #5: 16.2%).
doi:10.1371/journal.pone.0083179.g004
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of spiral waves, changes were again most pronounced for
compound #1 and #3.
Effects of IKur inhibition on stability of rotors
Besides being a powerful tool to easily assess the number of
spiral waves, our automated detection algorithm also opens up the
possibility to automatically track spiral-tip meandering. The spatial
arrangement of the spiral waves under control conditions showed
a rosette-like pattern with only minor movements of the rotor
centers (Figure 7A; color coded time scale with blue representing
early and red late time points). Similar results were obtained for
compounds #2, #4, and #5 (Figure 7C, 7E, 7F). In these cases,
no marked spatial instability of spiral tips could be observed. In
contrast, compounds #1 and #3 induced a pronounced tip
meandering resulting in the extinction of adjacent spiral waves.
These results are in line with the pronounced effects of these two
compounds on WL and might be best explained by a limitation of
the availability of non-refractory space. Figure 7B and 7D depict
Figure 5. Automated analysis of spiral wave activity. (A) Sequence of images (in 20 ms steps) of spiral wave activity under control cAF
conditions starting at the 10th second. The transmembrane voltage is color-coded with blue representing 280 mV and yellow representing 0 mV. (B)
Exemplary time interval (10th to 15th second) of the simulated unipolar pseudo-electrocardiogram (pseudo-ECG) recorded at the center of the atrial
layer under control conditions. (C) Normalized power spectral density of atrial activation derived from the pseudo-ECG. (D) Number of rotors
automatically detected by our analysis algorithm.
doi:10.1371/journal.pone.0083179.g005
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spiral tip meandering under inhibition with compound #1 and
#3.
Discussion
Using a mathematical model of human atrial tissue, we
analyzed the impact of time and voltage dependence of IKur
inhibitors on basic electrophysiological properties as well as
fibrillatory activity. Although inhibition of IKur failed to prolong
the terminal phase of the AP in normal atrial cells, a marked
prolongation could be observed in cAF cells. Similar results were
obtained for the ERP in the one-dimensional simulations. As
expected for pure potassium channel inhibitors, none of the model
compounds resulted in a marked change of the CV. Using two-
dimensional simulations of cAF tissue, the effects of the different
kinetic properties on fibrillatory activity were analyzed. Under
control conditions, a number of five stable spiral waves could be
induced. Interestingly, a relevant reduction of the number of
rotors could only be observed for two of the inhibitory compounds,
both resulting in pronounced spiral-tip meandering. We further
provide evidence that the observed anti-arrhythmic effect might be
due to a limitation of the non-refractory space.
Comparison with previous in silico models of AF
In our computational study, we used a modified Courtemanche-
Ramirez-Nattel (CRN) model of atrial electrophysiology including
electrophysiological remodeling. As reported previously by our
group, electrical remodeling was introduced by reducing the
maximum conductance of Ito and ICa,L to 65% and increasing the
maximum conductance of IK1 by 110% [17]. These modifications
result in an APD90 reduction from 300 ms to 129 which is
concordant with experimental data derived from human atrial
tissue [20]. Whereas current densities of Ito, ICa,L and IK1 were
altered similarly in the CAF2 case of Pandit’s model, they further
included a reduction of IKur by 50% [23]. For our experiments, we
decided not to include a reduction of IKur in order to better
visualize the differential impact of IKur blockade. However, in case
of a 50% downregulation of IKur, the control situation would be
expected to be identical to compound #5 (tonic blockade) in terms
of wavelength prolongation and wavelet count. Any further
inhibition of the downregulated current by the test compounds
would result in a further wavelength prolongation similar to our
observed effects. However, considering the smaller impact of the
downregulated IKur on repolarization, differences between the
kinetic properties of the test compounds would be less pro-
nounced. A significant difference between the models, however,
relates to gap junction remodeling. In order to include AF induced
alterations in connexin Cx40 expression, we decided to reduce the
conductance of the monodomain equation by 30% [17,21]. In our
opinion, this reduction correlates well to the clinical data revealing
a CV decrease of 20% in cAF atria [31]. Taken together, our
changes resulted in a marked reduction of the cardiac WL defined
as the distance traveled by the depolarizing wavefront during the
functional refractory period [32]. As the number of reentrant
circuits that fit into a certain area of atrial tissue depend on CV
and hence WL, up to five stable spiral waves could be induced in
our model. As discussed by Kneller et al. it is therefore tempting to
speculate that in case of a larger two-dimensional sheet or reduced
WL fibrillatory activity might more likely depend on multiple
wavelet reentry than a primary rotor [26].
Figure 6. Rotor analysis under pharmacological IKur inhibition. (A) Number of spiral waves followed over a time period of 30 seconds. (B)
Normalized power spectral density of electrical activity in remodeled tissue under control conditions and under IKur inhibition.
doi:10.1371/journal.pone.0083179.g006
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Insights into antiarrhythmic effects of IKur inhibition
Data from computational studies provide interesting insights
into antiarrhythmic mechanisms of different antiarrhythmic
compounds. For example, Kneller and co-workers elegantly
showed that pure sodium channel blockade results in AF
termination by enlargement of the center of rotation, increased
meandering of spiral tips and a reduction in the number of
secondary wavelets [30]. By analyzing the effects of potassium
current inhibition on wavelet stability in a computational model of
AF, Pandit and colleagues found that inhibition of IKur and Ito but
not IKr or IKs resulted in rotor termination [23]. However, the
inhibition was simulated by a simple reduction of the maximum
channel conductance without simulating any time or voltage
dependence of block. Tsujimae et al. developed a mathematical
model of voltage- and time-dependence of IKur inhibition [14].
Predicted from their model, an ideal anti-AF drug profile would
exhibit fast onset (5 ms) and slow recovery (1000 ms) kinetics [14].
However, the validity of this prediction has not been tested yet. To
test the hypothesis that antiarrhythmic properties of IKur inhibitors
depend on kinetic properties of inhibition, we introduced the
mathematical description of time- and voltage-dependence of
block in our in silico model of cAF. Compound #1 represents the
fictitious inhibitory profile recommended by Tsujimae et al. [14].
In contrast, compounds #2 (DPO-3) and #3 (DPO-1) relate to
existing kinetic profiles of a recently discovered group of potent
IKur inhibitors belonging to the group of diphenyl phosphine
oxides (DPO) [11,13,22]. Compound #4 was selected arbitrarily
in order to simulate the combination of slow onset and fast
recovery kinetics, and compound #5 represents the heterozygous
situation of a loss-of-function mutation without dominant negative
effects. As expected from the work of Tsujimae, compound #1
and #3 resulted in the most pronounced prolongation of the
wavelength (Figure 3D). It is well recognized, that spiral tip
trajectories strongly depend on the wavelength and the excitability
of the tissue (for review see [25]). Accordingly, the most
pronounced spatial instability could be observed for compounds
#1 and #3. From these results we conclude, that the prolongation
Figure 7. Effects of IKur inhibition on spiral tip meandering. Spatiotemporal arrangement of the spiral tips followed over a period of
30 seconds (color coded time scale: blue = early, red = late). Under control cAF conditions (A), five rotor centers were detected with high
spatiotemporal stability. Similar results were obtained for the inhibitory compounds #2 (C), #4 (E), and #5 (F). However, when applying the
compound #1 (B) or compound #3 (D), pronounced destabilization was observed paralleled by an extinction of rotors.
doi:10.1371/journal.pone.0083179.g007
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of the wavelength results in a limitation of non-refractory space
thereby resulting in spiral tip meandering and rotor extinction.
The results from our computational studies are underpinned by
experimental data obtained from the goat model of atrial
fibrillation [33]. Analyzing antiarrhythmic effects of the class III
antiarrhythmic compound AVE0118 on atrial fibrillation they
show that the IKur and Ito blocker AVE0118 dose-dependently
terminated persistent AF [33]. These results might come as
expected, as AVE0118 has been shown to efficiently prolong the
action potential in cardiomyocytes isolated from chronic AF
patients [6]. Within this context compound #3, which is highly
similar to the diphenyl phosphine oxide-1 (DPO-1), seems
particularly promising and should be further evaluated. Taken
together, drugs that efficiently prolong the wavelength in
remodeled atrial cells seem to be best candidates for potent
antiarrhythmics.
Limitations
The computational model used in this study represents a
simplification of the human situation in terms of 3D tissue
geometry, anisotropic fiber arrangement, as well as structural and
electrical heterogeneities: The analysis of spiral wave activity was
carried out in a small two-dimensional tissue sheet. As a
consequence, the influence of myocardial thickness as well as
gradients in myocardial thickness could not be addressed.
However, it is well recognized that the electrical dissociation
between the epicardial layer and the endocardial bundle network
increases the stability of AF by enlarging the area available for
reentry [34]. This effect can be further aggravated by structural
remodeling in the outer layer of the atria resulting in a reduction of
electrical coupling thereby further stabilizing AF [35]. On the
other hand, the existence of gradients in myocardial thickness
seems relevant for the perpetuation of AF, as scroll waves have
been shown to localize at the interface between thick and thin
regions [36]. As a consequence, it is tempting to speculate that
pharmacological effect of the test compounds might be less
pronounced as in a realistic 3D model of atrial tissue, as well as in
the human situation. Furthermore, it is well recognized that
abrupt changes in fiber orientation, that can be found in the
ostium of pulmonary veins, can result in activation delay and
conduction block [37]. These regions might promote ectopic
activity or microreentry thereby favoring the induction or
perpetuation of atrial fibrillation. As a limitation of the model,
the complexity of atrial fiber orientation was not included.
Fibrillatory activity was followed over a time period of 30 seconds.
Within this interval, two of the model compounds exerted relevant
antiarrhythmic effects, whereas all others resulted in no marked
reduction of spiral activity. However, none of the model
compounds resulted in a complete termination of all rotors. This
observation is somewhat contradictory to previously published
effects of IKur blockade in in silico models of AF [23]. However, by
reducing the CV, we presumably generated a substrate highly
susceptible to reentrant activity thereby rendering the simple
termination by ion channel inhibition more difficult.
Conclusion
Taken together, we provide evidence that antiarrhythmic effects
of IKur inhibitors are strongly dependent on kinetic properties of
blockade. Especially compounds with slow recovery kinetics result
in an effective prolongation of the wavelength thereby increasing
the area of refractory space. In these cases chaotic meandering of
spiral-tips leads to a reduction of reentrant circuits.
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